ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases The ERDERA Clinical Trial Call 2026 is open to fund multinational, sponsor-led, GCP-compliant Phase I, Phase I/II and Phase II interventional Clinical trials in rare...
Eirini Daskalopoulou joins Global Network for Rare Disease (GNRD)
Eirini Daskalopoulou’s Role in Shaping Global Rare Disease Care Pathways Rare Diseases International, in collaboration with Rare Care Centre and Wilhelm Foundation, is launching a Working Group to develop a Model Care Pathway for Rare Diseases adaptable to different...